Yagi, K., Imamura, T., Tada, H., Chujo, D., Liu, J., Shima, Y., Ohbatake, A., Miyamoto, Y., Okazaki, S., Ito, N., Nakano, K., Shikata, M., Enkaku, A., Takikawa, A., Honoki, H., Fujisaka, S., Origasa, H., & Tobe, K. (2021). diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction. Journal of diabetes research, 2021, . http://access.bl.uk/ark:/81055/vdc_100124370646.0x000007